Susquehanna Fundamental Investments, LLC Esperion Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$2.02 - $3.02 $336,243 - $502,700	166,457 New	166,457 $446 Million
Q1 2023 May 16, 2023	SELL	$1.46 - $7.3 $42,204 - $211,021	-28,907 Reduced 40.88%	41,809 $66,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $359,944 - $601,086	70,716 New	70,716 $440,000
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $575,981 - $1.09 Million	-50,792 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$19.4 - $28.71 $817,380 - $1.21 Million	42,133 Added 486.58%	50,792 $1.07 Million
Q1 2021 May 17, 2021	BUY	$25.12 - $36.89 $217,514 - $319,430	8,659 New	8,659 $243,000

199

136M

2.72M

1.3M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $144M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.